Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member., Inc. (NYSE:CRM): RiverPark Is Crazy About It

RiverPark Large Growth Fund is bullish on, Inc. (NYSE:CRM), a $98.33-billion market cap customer relationship management software provider. In its Q1 Investor Letter, RiverPark discussed its thesis on CRM. Let’s take a look at the fund’s comments. is also a software vendor that, like Oracle, sells Customer Relationship Management (CRM) software. Unlike Oracle, however, CRM was created as a subscription offering from inception and was one of the main pioneers of the software-as-a-service (SaaS) business model. The cloud computing/SaaS movement is now a $100 billion global market and CRM is now one of the fastest-growing large-cap software companies in the world.

CRM has consistently grown revenue at greater than 20% each year since its founding in 1999 to more than $10 billion in sales last year. We believe that through price increases and new products to cross-sell to its large customer base, Salesforce can continue to drive greater than 20% annual revenue growth for the long-term. In fact, following a 48% increase in the company’s backlog in its most recent quarter, Marc Benioff, the company’s CEO, said he’d “never seen a demand environment like this,” as companies accelerate their investments around digital transformation initiatives, which plays squarely into Salesforce’s strengths.

Most importantly to us, after years of profitless pursuit of top-line growth, a combination of operating leverage and recent cost discipline has resulted in 15% operating margins (and a greater than 60% growth in free cash flow) that we believe are poised to expand significantly. We believe the company’s ongoing growth and cost initiatives pave the way to 20%-25% operating margins over the next four years and greater than 30% longer term. Although CRM has been a strong stock during its transition to strong profit growth, we believe that a period of rapidly expanding profit and free cash flow growth will support continued outperformance of the company’s shares in the years to come.

banner, booth, business, cebit, company, computer, crowd, customer, design, electronics, equipment, event, exhibition, exhibitor, germany, group, hall, hannover, indoors, industrial, industry, information, innovation, interior, international, kiosk, logo, manufacturer, marketing, meeting, men, pavilion, people, presentation, professional, show, sign, spectator, stall, stand, technology, trade, vendor, visitors

Copyright: drserg / 123RF Stock Photo, Inc. (NYSE:CRM) is a popular stock among hedge funds covered by Insider Monkey. As of the end of 2017, there were 72 funds in our database with positions in the company including Tybourne Capital Management, Sachem Head Capital, and Duquesne Capital.

On Monday, CRM closed at $133.98. The stock jumped 55.47% over the past 12 months, while its year-to-date performance increased 28.32%. Over the past six months, CRM gained 29.24%. The stock has a consensus average recommendation of ‘Buy’ and a consensus average target price of $149.26, according to analysts polled by FactSet.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.